期刊文献+

IBMP-10评分方法在呼吸机相关性肺炎中的应用 被引量:2

Application of IBMP-10 score system in patients with ventilator-associated pneumonia
下载PDF
导出
摘要 目的研究IBMP-10评分方法在评估呼吸机相关性肺炎(VAP)病情危重程度及预测预后方面的价值。方法采用临床回顾性分析方法,将74例VAP患者按预后分为存活组和未存活组,分别应用IBMP-10评分方法和APACHEⅡ评分系统,在发生VAP当天作病情评分,比较IBMP-10评分方法和APACHEⅡ评分系统在评价VAP病情危重程度和预测预后方面的差异。结果存活组患者的IBMP-10评分值明显低于未存活组(P<0.01),且IBMP-10评分得分值越高,患者病死率越高;当得分值≥3分时,病死率达84.6%;预测死亡敏感性87.5%、特异性96.6%。IBMP-10评分方法和APACHEⅡ评分系统评估和预测能力无显著性差异。结论在评估VAP病情危重程度及预测预后方面,IBMP-10评分过程简单快速、方便记忆和使用,更具有临床实用性。 Objective To investigate the value of IBMP-10 score system in assessing the severity of ventilator-associated pneumonia(VAP) and its prognosis.Methods 74 patients with VAP were classified by prognosis into two groups: survival group and non-survival group.Both IBMP-10 and APACHE II were used as scores to evaluate the severity on the day of the VAP onset and the differences in the severity and prognosis of VAP between IBMP-10 score and APACHE II score system.Results IBMP-10 and APACHE II scores in survival group significantly decreased compared with non-survival group(P0.01).There was a positive correlation between the high IBMP-10 score and the rise of mortality;when the score was ≥3,the mortality was 84.6%;The prediction sensitivity to death was 87.5% and specificity was 96.6%.There were no significant differences between IBMP-10 and APACHE II scores in the predicting the disease severity and prognosis.Conclusion IBMP-10 score is a simple,rapid and convenient method easy to memorize and use in predicting the disease severity and prognosis in patients with VAP.
出处 《徐州医学院学报》 CAS 2010年第11期726-729,共4页 Acta Academiae Medicinae Xuzhou
关键词 IBMP-10评分 呼吸机相关性肺炎 预后 IBMP-10 score ventilator-associated pneumonia prognosis
  • 相关文献

参考文献11

  • 1Sinuff T,Muscedere J,Cook D,et al.Ventilator-associated pneumonia:Improving outcomes through guideline implementation[J].J Crit Care,2008,23(1):118-125.
  • 2Cook D.Ventilator associated pneumonia:perspectives on the burden of illness[J].Intensive Care Med,2002,26 (Supp1 1):S31-S37.
  • 3Chastre J,Fagon JY.Ventilator-associated pneumonia[J].Am J Respir Crit Care Med,2002,165(7):867-903.
  • 4Gursel G,Demirtas S.Value of APACHE II,SOFA and CPIS scores in predicting prognosis in patients with ventilator-associated pneumonia[J].Respiration,2006,73(4):503-508.
  • 5医院获得性肺炎诊断和治疗指南(草案)[J].中华结核和呼吸杂志,1999,22(4):201-208. 被引量:2163
  • 6Mirsaeidi M,Peyrani P,Ramirez JA.Predicting mortality in patients with ventilator-associated pneumonia:The APACHE II score versus the new IBMP-10 score[J].Clin Infect Dis,2009,49(1):72-77.
  • 7Hyllienmark P,Grdlund B,Persson JO,et al.Nosocomial pneumonia in the ICU:a prospective cohort study[J].Scand J Infect Dis,2007,39(8):676-682.
  • 8Matic I,Titlic M,Dikanovic M,et al.Effects of APACHE II score on mechanical ventilation; prediction and outcome[J].Acta Anaesthesiol Belg,2007,58(3):177-183.
  • 9曾晖,江东新,蔡立华,覃丙军.APACHEⅡ评分在呼吸机相关性肺炎中的应用[J].临床医学,2007,27(6):16-17. 被引量:14
  • 10邹莉玲,余小金,闵捷,沈其君.ROC曲线在医学诊断中的应用与进展[J].东南大学学报(医学版),2003,22(1):67-70. 被引量:46

二级参考文献17

共引文献2230

同被引文献41

  • 1王泽宇,吴允孚.C反应蛋白检测在治疗呼吸机相关性肺炎中的作用[J].实用老年医学,2013,27(1):38-40. 被引量:22
  • 2秦志强,王辰.急性呼吸衰竭诊疗进展[J].内科急危重症杂志,2004,10(4):221-222. 被引量:11
  • 3Huang KT,Tseng CC,Fang WF,et al.An Early Predictor of Patients with Ventilator-associated Pneumonia[J].Chang Gung Med J,2010,33(3):274-281.
  • 4Wiskirchen DE,Kuti JL,Nicolau DP.Acute physiology and chronic health evaluationⅡscore is a better predictor of mortality than IBMP-10 in patients with ventilator-associated pneumonia[J].Surg Infect(Larchmt),2011,12(5):385-390.
  • 5Zilberberg MD,Shorr AF.Ventilator-associated pneumonia:the clinical pulmonary infection score as asurrogate for diagnostics and outcome[J].Clin Infect Dis,2010,51 Suppl 1:S131-135.
  • 6Tseng CC,Huang KT,Chen YC,et al.Factors predicting ventilator dependence in patients with ventilator-associated pneumonia[J].Scientific World Journal,2012,2012:547241.
  • 7Siempos II,Vardakas KZ,Kyriakopoulos CE,et al.Predictors of mortality in adult patients with ventilator-associated pneumonia:a meta-analysis[J].Shock,2010,33(6):590-601.
  • 8Stolz D,Smyrnios N,Eggimann P,et al.Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia:a randomised study[J].Eur Respir J,2009,34(6):1364-1375.
  • 9Seligman R,Seligman BG,Teixeira PJ.Comparing the accuracy of predictors of mortality in ventilator-associated pneumonia[J].J Bras Pneumol,2011,37(4):495-503.
  • 10Rumende CM,Dinajani M.Role of combined procalcitonin and lipopolysaccharide-binding protein as prognostic markers of mortality in patients with ventilator-associated pneumonia[J].Acta Med Indones,2013,45(2):89-93.

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部